SCHEMBL8638006

SCHEMBL8638006

FC(F)(F)COc1ccc(Cl)cc1CNC1CCCNC1c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 19/20 0.74
CYP2D6 P10635 5/20 0.62
KCNH2 Q12809 1/20 0.60
HTR1A P08908 1/20 0.59
HTR2A P28223 1/20 0.59
HTR2C P28335 1/20 0.59
HRH1 P35367 1/20 0.59
HTR2B P41595 1/20 0.59
SLC6A3 Q01959 1/20 0.59
TMEM97 Q5BJF2 1/20 0.59
SIGMAR1 Q99720 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4918321 1.00 TACR1 (0.74) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL6424808 0.99 TACR1 (0.72) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL4913489 0.99 TACR1 (0.72) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL4907096 0.89 TACR1 (0.72) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL4917005 0.88 TACR1 (0.77) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL4914589 0.87 TACR1 (0.75) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6708199 0.86 TACR1 (0.76) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6699054 0.86 TACR1 (0.70) TACR1CYP2D6KCNH2HTR1AHTR2A
SCHEMBL6699080 0.86 TACR1 (0.76) TACR1CYP2D6KCNH2HTR1AHTR2A
Hydrochloric Acid SCHEMBL4917057 0.85 TACR1 (0.75) TACR1CYP2D6KCNH2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854720-A1 NK-1 RECEPTOR ANTAGONISTS FOR PREVENTION OF NEUROGENIC INFLAMMATION IN GENE THERAPY PFIZER INC. (US) 1998-07-29 EP disclosed
WO-1997013514-A1 NK-1 RECEPTOR ANTAGONISTS FOR PREVENTION OF NEUROGENIC INFLAMMATION IN GENE THERAPY PFIZER INC. (US) 1997-04-17 WO disclosed